Non-invasive prenatal testing

Testing for genetic conditions and traits such as Down’s syndrome now can be carried out by means of a blood test from 10 weeks of pregnancy. This kind of testing is more accurate than previously available early screening tests and does not carry the risk of miscarriage of invasive diagnostic tests. However, concerns have been raised including about routinisation and the potential for non-invasive prenatal testing to provide wider genetic information about the unborn child.

This project will explore the ethical, legal and regulatory implications of recent and potential future scientific developments in non-invasive prenatal testing, including its use in both NHS and commercial services.

Project updates

Previous work

Contact us

Nuffield Council on Bioethics
28 Bedford Square
London
WC1B 3JS

bioethics@nuffieldbioethics.org

+44 (0)20 7681 9619

Get regular e-news

Community

Explore by topic